Clinical validation of host biomarker signature for distinguishing bacterial versus viral lower respiratory tract infections (LRTI) in adults at the point-of-need

Informations projet

Respiratory-ImmunoDx

N° de convention de subvention: 684589

DOI 10.3030/684589

Projet clôturé

Date de signature de la CE 27 Novembre 2015

Date de début 1 Decembre 2015

Date de fin 30 Novembre 2018

Financé au titre de

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coût total € 2 935 000,00

Contribution de l’UE € 2 935 000,00

Coordonné par

MEMED DIAGNOSTICS LTD
Israel

Livrables

Websites, patent fillings, videos etc. (2)

A dedicated website for OBSERVER and ImmunoDx™

D6.1 A dedicated website for OBSERVER and ImmunoDx™

Presenting at infectious disease conference

D6.2 Presenting OBSERVER study results in an infectious disease conference